Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katarina Lilja
Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden
Biologics in Therapy
Related publications
Response To: ‘Mandatory, Cost-Driven Switching From Originator Etanercept to Its Biosimilar SB4: Possible Fallout on Non-Medical Switching’ by Cantini and Benucci
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
A Real Concern or Just a Hype? – Evidence on Negative Clinical Consequences of Switching From Originator to Biosimilar Based on a Systematic Literature Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
CPC-003 a Retrospective Analysis of the Switches From Originator and Biosimilar Recombinant Human Erythropoietins in Chronic Kidney Disease
European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
Hot Flushes, Hormone Therapy and Alternative Treatments: 30 Years of Experience From Sweden
Climacteric
Medicine
Gynecology
Obstetrics
Switching to Omnitrope® From Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System
Biologics in Therapy
How Safe Is Conversion From Tacrolimus to Its Generic Drug?—A Single Center Experience
Open Journal of Nephrology
Clinicopathological Features of Myeloid Sarcoma Patients From a Single Center Experience
TURKISH MEDICAL STUDENT JOURNAL
Switching From Originator Biological Agents to Biosimilars: What Is the Evidence and What Are the Issues?
RMD Open
Rheumatology
Allergy
Immunology
Predicting Bull Growth Performance and Carcass Composition From Growth Hormone Response to Growth Hormone-Releasing Hormone.
Journal of Animal Science
Animal Science
Zoology
Genetics
Medicine
Food Science
